SCHEMBL2222239

SCHEMBL2222239

CC(C=O)=C(c1ccccc1)c1ccccc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.50
MAPK1 P28482 1/20 0.50
TDP1 Q9NUW8 1/20 0.50
TSHR P16473 3/20 0.45
CES2 O00748 3/20 0.44
CES1 P23141 3/20 0.44
ESR1 P03372 1/20 0.43
PTGS2 P35354 2/20 0.41
DAO P14920 1/20 0.40
NAPRT Q6XQN6 1/20 0.40
HDAC3 O15379 1/20 0.40
HDAC4 P56524 1/20 0.40
HDAC1 Q13547 1/20 0.40
HDAC7 Q8WUI4 1/20 0.40
HDAC2 Q92769 1/20 0.40
HDAC10 Q969S8 1/20 0.40
HDAC11 Q96DB2 1/20 0.40
HDAC8 Q9BY41 1/20 0.40
HDAC6 Q9UBN7 1/20 0.40
HDAC9 Q9UKV0 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20400500 0.88 CES2 (0.52) ALDH1A1MAPK1TDP1TSHRCES2
SCHEMBL894842 0.81 ALDH1A1 (0.50) ALDH1A1MAPK1TDP1TSHRCES2
SCHEMBL9520116 0.81 ALDH1A1 (0.50) ALDH1A1MAPK1TDP1TSHRCES2
SCHEMBL15122603 0.81 ALDH1A1 (0.50) ALDH1A1MAPK1TDP1TSHRCES2
SCHEMBL28286028 0.80 PTGS1 (0.49) ALDH1A1MAPK1TDP1CES2CES1
SCHEMBL6711029 0.80 HPGDS (0.51) ALDH1A1MAPK1CES2CES1DAO
SCHEMBL1825343 0.77 ESR1 (0.51) ALDH1A1MAPK1TDP1TSHRCES2
SCHEMBL1825340 0.77 ESR1 (0.51) ALDH1A1MAPK1TDP1TSHRCES2
SCHEMBL12657759 0.77 ESR1 (0.51) ALDH1A1MAPK1TDP1TSHRCES2
SCHEMBL9855705 0.77 CES2 (0.44) CES2CES1PTGS2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2216312-B1 PROCESS FOR PRODUCING ORGANIC COMPOUND M TECHNIQUE CO LTD (JP) 2019-05-01 EP disclosed
CN-104193660-B Substituted 1,3- diphenyl propane derivatives, their preparation and purposes 基恩菲特 2018-10-19 CN disclosed
EP-2371831-B1 PROCESS FOR PRODUCING ORGANOLITHIUM COMPOUND AND PROCESS FOR PRODUCING SUBSTITUTED AROMATIC COMPOUND NIPPON SODA CO (JP) 2016-09-07 EP disclosed
US-9133098-B2 Process for producing organolithium compound and process for producing substituted aromatic compound NIPPON SODA CO., LTD. (JP) 2015-09-15 US disclosed
US-20150025276-A1 PROCESS FOR PRODUCING ORGANOLITHIUM COMPOUND AND PROCESS FOR PRODUCING SUBSTITUTED AROMATIC COMPOUND NIPPON SODA CO., LTD. (JP) 2015-01-22 US disclosed
US-8871970-B2 Process for producing organolithium compound and process for producing substituted aromatic compound NIPPON SODA CO., LTD. (JP) 2014-10-28 US disclosed
US-8592498-B2 Method for producing organic compound and organic compound obtained by the method M. TECHNIQUE CO., LTD. (JP) 2013-11-26 US disclosed
EP-2371831-A1 PROCESS FOR PRODUCING ORGANOLITHIUM COMPOUND AND PROCESS FOR PRODUCING SUBSTITUTED AROMATIC COMPOUND Nippon Soda Co., Ltd. (JP) 2011-10-05 EP disclosed
US-20110224457-A1 PROCESS FOR PRODUCING ORGANOLITHIUM COMPOUND AND PROCESS FOR PRODUCING SUBSTITUTED AROMATIC COMPOUND NIPPON SODA CO., LTD. 2011-09-15 US disclosed
US-20110178199-A1 METHOD FOR PRODUCING ORGANIC COMPOUND AND ORGANIC COMPOUND OBTAINED BY THE METHOD M. TECHNIQUE CO., LTD. (JP) 2011-07-21 US disclosed
EP-1253152-B1 METHOD OF CONVERTING FUNCTIONAL GROUP THROUGH HALOGEN-METAL EXCHANGE REACTION BANYU PHARMA CO LTD (JP) 2009-11-04 EP disclosed
US-7572927-B2 Method of producing an o-disubstituted aromatic compound, and method of producing a monosubstituted-monohaloaromatic compound FUJIFILM CORPORATION (JP) 2009-08-11 US disclosed
US-7439535-B2 Process for exchanging functional groups by halogen-metal exchange reaction BANYU PHARMACEUTICAL CO., LTD. (JP) 2008-10-21 US disclosed
US-20080194816-A1 Method of producing an o-disubstituted aromatic compound, and method of producing a monosubstituted-monohaloaromatic compound FUJIFILM CORPORATION (JP) 2008-08-14 US disclosed
US-6946559-B2 Replacing a halogen atom with an electrophilic group (e.g., a formyl group) using either a mixture of an organomagnesium halide and an alkyllithium or a reaction product of the two, such as trialkylmagnesium lithium BANYU PHARMACEUTICAL CO., LTD. (JP) 2005-09-20 US disclosed
US-20050156336-A1 Process for exchanging functional groups by halogen-metal exchange reaction MSD K.K. (JP) 2005-07-21 US disclosed
US-20050104233-A1 Method of substituent introduction through halogen-metal exchange reaction BANYU PHARMACEUTICAL CO., LTD. (JP) 2005-05-19 US disclosed
EP-1510510-A1 METHOD OF SUBSTITUENT INTRODUCTION THROUGH HALOGEN-METAL EXCHANGE REACTION BANYU PHARMACEUTICAL CO., LTD. (JP) 2005-03-02 EP disclosed
US-20030130511-A1 Method of converting functional group through halogen-metal exchange reaction MSD K.K. (JP) 2003-07-10 US disclosed
EP-1253152-A1 METHOD OF CONVERTING FUNCTIONAL GROUP THROUGH HALOGEN-METAL EXCHANGE REACTION BANYU PHARMACEUTICAL CO., LTD. (JP) 2002-10-30 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080194816-A1 Method of producing an o-disubstituted aromatic compound, and method of producing a monosubstituted-monohaloaromatic compound DDT, OXER1, OSTC ALDH1A1 1259/4885MAPK1 2478/4885TDP1 4535/4885
US-20050156336-A1 Process for exchanging functional groups by halogen-metal exchange reaction SLC39A11, MLX, SLC39A14 ALDH1A1 4684/4885MAPK1 1780/4885TDP1 4595/4885
US-20050104233-A1 Method of substituent introduction through halogen-metal exchange reaction SLC39A11, SLC30A6, SLC39A3 ALDH1A1 1890/4885MAPK1 3057/4885TDP1 4836/4885
US-20030130511-A1 Method of converting functional group through halogen-metal exchange reaction MLX, HAX1, ZFX ALDH1A1 4406/4885MAPK1 1586/4885TDP1 4526/4885
US-20110178199-A1 METHOD FOR PRODUCING ORGANIC COMPOUND AND ORGANIC COMPOUND OBTAINED BY THE METHOD OR10J3, PORCN, ABCG2 ALDH1A1 3191/4885MAPK1 3660/4885TDP1 1880/4885
US-20110224457-A1 PROCESS FOR PRODUCING ORGANOLITHIUM COMPOUND AND PROCESS FOR PRODUCING SUBSTITUTED AROMATIC COMPOUND C9, TRPA1, PKD1 ALDH1A1 4118/4885MAPK1 2260/4885TDP1 4590/4885
US-20150025276-A1 PROCESS FOR PRODUCING ORGANOLITHIUM COMPOUND AND PROCESS FOR PRODUCING SUBSTITUTED AROMATIC COMPOUND C9, TRPA1, PKD1 ALDH1A1 4118/4885MAPK1 2260/4885TDP1 4590/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.